Figure 9

In vivo evaluation of the flow-through blood detector. Comparison between the blood TAC obtained with the developed flow-through detector (grey squares) or obtained by manual sampling (black circle) after injection of (A) 5.5 MBq [¹⁸F]ciprofloxacin, (B) 55.1 MBq [¹¹C]mephobarbital, (C) 6.9 MBq [¹⁸F]FDG, (D) 57.9 MBq (R)-[¹¹C]verapamil, (E) 39.7 MBq [¹¹C]tariquidar and (F) 97.4 MBq [¹¹C]MC113. In contrast to (B), (C), (D), (E) and (F), the variable integration time was not active during the TAC record in figure (A) causing much larger variation of the values. All TACs are corrected for radioactive decay.